Heat Biologics Inc

NASDAQ:HTBX  
3.03
-0.06 (-1.94%)
Products

Heat Biologics Announces New PTX-35 Preclinical Data In Organ Transplantation And Provides Update On HS-110

Published: 01/12/2022 13:27 GMT
Heat Biologics Inc (HTBX) - Heat Biologics Announces New Ptx-35 Preclinical Data in Organ Transplantation and Provides Update on Hs-110.
Heat Biologics Inc - a Single Dose of Preclinical Version of Ptx-35 (mptx-35), Was Able to Expand Regulatory T Cells.
Heat Biologics Inc - Long-term Surviving Grafts Showed a Marked Increase in Treg Infiltration Which Directly Correlated With Mptx-35 Agonist Activity.